• Febrero 1997 (inglés) • Abril 1998 (inglés) • Noviembre 1998 (inglés)
• Invierno 1999 (inglés) • Primavera 1999 (inglés) • Primavera 2000 (inglés)
• Invierno 2000 (inglés) • Primavera 2001 (inglés)
|
The
Emergency Contraceptive Newsletter Fall
2000 Vol.
5, No. 2 ABOUT
THIS NEWSLETTER: This
newsletter is prepared and distributed as a voluntary activity on behalf
of the American Society for Emergency Contraception and the
international Consortium for Emergency Contraception.
It is distributed electronically twice each year to anyone who
wishes to receive it. To
contribute a news item, please send it to AmSocEC@aol.com
, to Tara Shochet (shochet@princeton.edu),
or to Charlotte Ellertson (cellertson@popcouncil.org.mx).
Annik Sorhaindo (asorhaindo@popcouncil.org.mx)
is currently the editor of the newsletter, but will retire as of
December 31st 2000. We
reserve the right to check and edit items as appropriate.
To join or remove your name from the newsletter circulation list,
please write to AmSocEC@aol.com.
To learn more about ASEC and the International Consortium on EC, look at
the end of this newsletter. ****NorLevo
still available through ASEC**** NorLevo,
a progestin-only EC product, was recently approved in France for
pharmacist provision. Due
to the change in labeling required when the product moved from
prescription-only status to pharmacist provision or p status, HRA
Pharma, the company marketing NorLevo, had to recall a large amount of
the product. Last year,
they generously made these supplies available for research or
humanitarian purposes through ASEC.
The offer was made with the following provisions:
Please
contact ASEC if your organization is interested in obtaining supplies of
Norlevo. Please provide us
with the amount of product you would like to receive, the purpose for
which you intend to use it, and where it should be shipped.
ASEC has agreed to serve as a clearing house for requests, and
requests will be considered on a first-come, first-serve basis. There
are still 20,000 boxes available. The product expiration date is April
2001, so hurry and place your order! Contact:
Andre
Ulmann HRA-Pharma
63, Rue de la Colonie 75013,
Paris FRANCE Tel:
33-1-4033-1130
Fax:
33–1-40-33-1231 Email:infohra@hra-pharma.com
Tara
Shochet Office
of Population Research Princeton
University Notestein
hall 21
Prospect Street Princeton,
NJ 08544 USA Tel:
609-258-5402 Fax:
609-258-1039 Email:
shochet@princeton.edu PRODUCT NEWS Discounted PREVEN available without
pregnancy test The
emergency contraceptive kit, PREVEN, is now available to clinics without
a pregnancy test. The new kit’s wholesale price is $15.95. The regular
kits are still available in the public sector for between $2.05 and
$2.25. More expensive kits
containing pregnancy tests are available in most pharmacies. Contact: Richard Grace Gynetics
Inc. 105
Raider Boulevard Suite
203 Belle
Mead, NJ 08502 USA Tel:
908-359-2429 Fax:
908-359-6660 Email:
gynetics@aol.com Plan B now has 18 month expiration date The
U.S. Food and Drug Administration recently lengthened Plan B’s
expiration date to 18 months. The longer expiration date helped to move
Plan B into retail distribution in August. The expiration date is
expected to be lengthened again to 24 months by the end of November
2000. Contact: Sharon
Camp Women’s
Capital Corporation 8930
Camp Road Wellcome,
MD 20693 USA Tel:
301-753-1926 Fax:
301-753-1927 Email:
scamp8930@aol.com
Dedicated products approved in Latin
America This
summer, the dedicated levonorgestrel emergency contraceptive product
marketed by HRA Pharma, NorLevo, was approved in Brazil and Peru. In
Mexico, it should be approved soon and will be sold under the trademark
Vikela. Also
in Mexico, Postinor 2 has also been approved and will be available in
pharmacies in January 2001. Füstery, the organization distributing
Postinor 2 in Mexico, says they will apply for over the counter status
within one year of the product’s release. It will be sold in the
private sector for about $5. Contact: André
Ulmann HRA
Pharma 63, Rue de la Colonie 75013 Paris FRANCE Tel: 33-1-4033-1130 Fax: 33–1-40-33-1231 Email: infohra@hra-pharma.com Raffaela Schiavon Population Council Escondida 110 Colonia Coyoacan México
DF 04000 MÉXICO Tel:
525-659-8839 Fax:
525-554-1226 Email:
rschiavon@popcouncil.org.mx Levonelle-2 approved in the UK, may go OTC In
February 2000, Levonelle-2, a progestin-only dedicated EC, was approved
in the UK on a prescription-only basis. Before the introduction of
Levonelle-2, the only other dedicated product available was the Yuzpe
regimen, Schering PC4. Although PC-4 is less expensive, many EC
providers throughout the country are prescribing Levonelle-2, citing
reduced side effects. Also
this year, Schering Health Care Ltd. applied for the removal of the
prescription-only status on Levonelle-2. The Medicines Control Agency
submitted a recommendation to reclassify the product for over the
counter pharmacy sale to women 16 and older.
A change in classification must first be approved by health
ministers and ratified by the parliament.
If approved by the parliament, the Medicines Control Agency could
change the license on the product before the end of the year and
Schering Ltd. would make the product available in stores sixteen weeks
later. Although there is support for reclassification, many see a middle
ground, particularly if experiments with pharmacist distribution (see
later story in this newsletter) prove to be successful and are
instituted nationally. Moreover, there is concern that pharmacy sale
without a prescription would lead to over use. EC advocates in the UK
hope that some combination of pharmacist distribution and over the
counter sales will increase access to women nationwide. Contact: Ann
Furedi Director
of Communications British
Pregnancy Advisory Service Austy
Manor, Wootton Wawen, Solihull West
Midlands B95 6BX UNITED
KINGDOM Tel:
44-156-4796-1033 Fax:
44-020-7580-2995 Email:
anne-furdi@easynet.co.uk EC approved for sale in Italy, Vatican
backyard
In
early October, the Italian Health Ministry approved the sale of NorLevo.
The emergency contraceptive is now available with prescription through
Italian pharmacies. Monsignor Elio Sgreccia, the Vatican’s leader on
bioethical issues expressed the church’s disapproval of the decision.
He said the decision was an appeal to women who oppose abortion but
accept contraception. He added, “In reality, the fertilized egg is an
embryo and an embryo is an individual human being, Therefore, blocking
the implantation in the uterus is the same as suppressing it. Morally,
it’s the same thing as a surgical abortion”. Contact: Andre
Ullman HRA
Pharma 63, Rue de la Colonie 75013
Paris FRANCE Tel:
33-1-4033-1130
Fax:
33–1-40-33-1231 Email:
infohra@hra-pharma.com COUNTRY UPDATES EC goes over the counter in
British Columbia, Canada
Beginning
December 1st in British Columbia, Canada, emergency
contraceptive pills will be available
from a pharmacist without a prescription. In late October, the Cabinet
changed regulations to allow pharmacists prescriptive authority for
emergency contraception. Under the new regulation, pharmacists must take
a half day training session to become certified providers. So far, over
800 have already received certification. The pills cost between $8 and
$15 and are available to all women regardless of age.
A public education campaign is scheduled for the December 1st
launch. Contact: Judith
Chrystal Director,
Communications British
Columbia Pharmacy Association Richmond,
BC V6X
2W2 CANADA Tel:
604-279-2053 Fax:
604-279-2065 Email:
judith@bcpharm.bc.ca
Ontario Women’s Health Council pilot
project puts EC over the counter
Next
spring, the Ontario Women’s Health Council will begin a pilot project
to allow women to get emergency contraception from Ontario pharmacies
without a prescription. The two year research project is designed to
develop recommendations for the best way to make the method available to
women. The Ontario Women’s Health Council hopes to reduce unwanted
teenage pregnancy through this project. Although they have not yet
confirmed the sites, they expect to run the project through 24-hour
pharmacies in high density areas of Greater Toronto. The pilot won
preliminary support from the Ontario College of Pharmacists, the
Canadian Medical Association and the Society of Obstetricians and
Gynecologists. Contact: Jane
Pepino Women’s
Health Council 880
Bay Street 4th
Floor Toronto,
Ontario M7A 1R3 CANADA Tel:
416-327-8348 Fax:
416-327-3200 US
Senators block funding ban for emergency contraception in schools In
September, the U.S. House of Representative approved a Senate provision
in the FY 2001 Labor, Health and Human Services, and Education
Appropriations bill to outlaw the use of federal funds to distribute
emergency contraception in elementary and secondary schools. The bill,
written by Senator Jesse Helms from North Carolina, will affect at least
180 schools that currently provide EC to students.
Contact: Alison
Browett Kaiser
Daily Reports 1501
M St. NW Washington,
DC 20005 USA Tel:
202-672-5952 Fax:
202-672-5767 Email:
report@kff.org NGOs in Latin America consider creating a
consortium for the region As
part of the two-day International Consortium for Emergency Contraception
meeting in October, representatives from
NGOs in Latin America met for a third day to plan for a Latin
American Emergency Contraception Consortium.
Representatives from several organizations in Latin America came
to New York to discuss the region’s needs regarding emergency
contraception and how forming a consortium among organizations in the
region may address those needs. The
LAC EC Consortium would be modeled after the International Consortium,
but with a focus on issues concerning the Latin America and the
Caribbean. The group was enthusiastic, but are still in the planning
stages. Contact: Angela
Heimburger Population
Council Escondida
110 Col.
Coyoacan Mexico
DF 04000 Tel:
525-659-8839 Fax:
525-554-1226 Email:
aheimburger@popcouncil.org.mx
PIWH
collaborates with NGOs in Latin America to increase knowledge about EC For
the past several years, the Pacific Institute for Women’s Health
(PIWH) has worked together with NGOs throughout Latin America to
increase availability of and knowledge about emergency contraception
throughout their communities. Recently, PIWH presented EC workshops for
women’s groups and health professionals in Nicaragua, Brazil and
Mexico. Soon they will work with a collective of seven NGOs in El
Salvador to conduct workshops throughout the country. Contact: Angeles
Cabria Barbara
Pillsbury 2999
Overland Avenue, Suite 111 Los Angeles, California 90064 USA Tel:
310-842-6828 Fax:
310-280-0600 Email:
acabria@piwh.org Profamilia works to bring EC to Colombia Profamilia,
the International Family Planned Parenthood Federation (IPPF) affiliate
in Colombia, has been working for several years to increase awareness
and access to emergency contraception in the country. This year,
Profamilia’s social marketing department ran a series of radio spots
and magazine ads on emergency contraception aimed at young adults. Since
the advertisements, Profamilia has received an increase in the number of
calls made to the clinic for emergency contraception. Profamilia
is also registering Postinor 2 in Colombia. They expect it to be
available in pharmacies this fall. Contact: Maria
Isabel Plata Profamilia Calle
34, No 14-52 Santa
Fe de Bogota Bogota COLOMBIA Tel:
571-338-3160 Fax:
571-338-3159 Email
info@profamilia.org.co EC questions to be
added to nation-wide health surveys in Honduras and Brazil The
Honduran Encuesta Nacional de Epidemiologia y Salud de la Familia
(ENESF) for 2001 will include several questions on EC. The nation-wide survey is run by USAID, U.S. Centers for
Disease Control, and the International Planned Parenthood Federation
affiliate in Honduras, ASHONPLAFA. They added emergency contraception as
an option to many of the survey’s standard contraception questions and
also added several new questions on EC. The Brazil DHS may also add four
questions on emergency contraception to its 2000 DHS questionnaire. They
plan to contact the U.S. Centers for Disease Control as well as Macro
International to recommend that they include questions on EC in all of
their future surveys. Contact: Sandra
Garcia Population
Council Escondida
110 Col.
Coyoacan México
DF 04000 MÉXICO Tel: 525-659-8839 Fax:
525-554-1226 Email: sgarcia@popcouncil.org.mx Irma
Mendoza Population
Council Residencial
Casavola No. 37 Area
Bancatlan, Miraflores Tegucigalpa HONDURAS Tel: 504-232-6021 Fax: 504-239-5449 Email:irma@mayanet.hn Loren Galvao Population
Council Caixa
Postal 6509, Ciudad Universitaria 13084-970
Campinas Sao
Paulo BRAZIL Tel: 55-19-3-249-0121 Fax:
55-19-3-249-0216 Email: lgalvao@popcouncil.org.br
APPRENDE moves into Phase II of their
program to introduce EC to Venezuela Since
1993, the Asociacion Para la Prevencion de Embarazos No Deseados
(APRRENDE) has worked to introduce EC to Venezula. As part of Phase I, they researched both prospective providers and
potential users of EC in the country, informed several gynecologists
about the method and registered Postinor 2 for sale in Venezuela.
Phase II of the introduction began in March this year. Based on
the results of Phase I, APPRENDE designed and distributed an array of
informational materials and trained providers about EC through workshops
at their annual professional conferences. They also installed a 24 hour
EC hotline (576-3DIAS) where
women can get information and referrals for emergency contraception to
nearly 1000 providers. Following
the March 2000 launch, several Venezuelan media ran stories, interviews
and dedicated entire programs to discussion of emergency contraception.
By the end of August, APPRENDE had sold over 20,000 cycles of Postinor
2. In its first month of operation, the EC hotline received 1,038 calls
and is currently receiving about 30 calls a day. Unlike other hotlines,
this one is not toll-free. Although,
APPRENDE considers the introduction of EC to Venezuela a success, they
have identified parts of the program that need improvement. They want to
design a EC training course for providers and further educate pharmacy
staff about the method. In addition to their current media efforts,
APPRENDE wants to fund a toll-free number for the hotline and advertise
it through television spots. Contact: Alan Lambert APPRENDE Torre Mayo Piso 1 Oficina 1-C Av. Eraso, entre Avs. Panteón y Sorocaima San Bernardino Caracas VENEZUELA Tel: 58-2-575-0272 Fax: 58-2-576-5010 Email
: prosalud@cantv.net In
the UK, BPAS clients not interested in advanced prescriptions for EC The
demand for prescription for emergency contraception in advance of need
has been lower than expected at the British Pregnancy Advisory Service
(BPAS). Doctors involved in
recent advanced provision projects say that their clients seem to be as
embarrassed to admit that they may have unprotected sex and may need EC
in the future as they are to admit that they have had unprotected sex in
the past 72 hours. Even women who present for abortions claim that they
do not need ECs in advance because they will not risk pregnancy again.
BPAS thought this program could help to make women feel as though they
were taking responsibility for their reproductive health by preparing
for unprotected sex, but instead they found that women are reluctant to
acknowledge that they need to take such precautions. Contact: Ann
Furedi Director
of Communications British
Pregnancy Advisory Service Austy
Manor, Wootton Wawen, Solihull West
Midlands B95 6BX UNITED
KINGDOM Tel:
44-156-4796-1033 Fax:
44-020-7580-2995 Email:
anne-furdi@easynet.co.uk EC available in a British airport The
Manchester Airport in Britain now offers emergency contraception to
travelers through a drop-in health center located in Terminal One. From
the health center, travelers can get advice on STDs, emergency
contraception kits and condoms. The health center is staffed by 18
nurses who are trained to treat a wide range of ailments from travel
sickness to heart attacks. Patients do not need an appointment. Contact: Allison
Browett Kaiser
Daily Reports 1501
M St., N.W. Washington,
DC 20005 USA Tel:
202-672-5952 Fax:
202-672-5767 Email:
report@kff.org EC again available to through schools in
France In
early October, the French National Assembly voted to allow the
distribution of the emergency contraceptive brand NorLevo to minors
without parental consent or a doctor’s prescription. The vote
overturned an earlier ruling that prohibited school nurses from giving
EC to students. NorLevo is a levonorgestrel-only product distributed by
HRA Pharma. Contact: Andre Ullman HRA Pharma 63, Rue de la Colonie 75013
Paris FRANCE Tel:
33-1-4033-1130
Fax:
33–1-40-33-1231 Email:
infohra@hra-pharma.com Media campaign raises EC awareness in India Staff
at the Population Council in India recently completed work on a media
campaign to increase awareness and knowledge about emergency
contraception among providers and potential users. As part of the
campaign, several leading newspapers, magazines, radio and television
programs ran messages on EC. Researchers evaluated the success of the
campaign by assessing the medias’ willingness to run messages on EC
and by determining which populations were reached by the campaign. Staff
at the Council continue to disseminate information on emergency
contraception and to work closely with the Indian government and other
NGOs to integrate emergency contraception into reproductive health
programs throughout the country. Contact: Anjali
Nayyar Population
Council Ground
Floor, Zone 5A Habitat
Center Lodi
Road INDIA Tel:
91-11-464-2901 Fax:
91-11-464-2903 Email:
anjali@pcindia.org The Population Council studies public
sector EC provision Researchers
at the Population Council in Bangladesh are examining methods of
providing EC in public sector clinics. They are studying approaches that
build on traditional practices of inducing menstruation to find out the
most effective way to make EC available to the population.
Through the national program, oral contraceptives will be
available to women living in rural areas. The best program will be
measured by reduction in abortions and miscarriages and actual EC use.
The study will also provide a gauge for acceptable dedicated product
pricing. Contact: Anjali
Nayyar Population
Council Ground
Floor, Zone 5A Habitat Center Lodi Road INDIA Tel: 91-11-464-2901 Fax: 91-11-464-2903 Email: anjali@pcindia.org DKT
International train pharmacists in the Philippines about ECPs Since
late 1999, DKT International has been conducting training sessions on
contraception for pharmacists and their assistants in 6 to 8 urban areas
in the Philippines. The program focuses on providing OCs for use in
emergency contraception. The project aims to train 520 pharmacists and
950 assistants by May 2001. They also plan to develop referral systems
and to distribute information on EC in the communities of each of the
target areas. Contact: Andrew
Piller DKT
International 1120
19th Street, NW Washington,
DC 20036 USA Tel:
202-785-0094 Fax:
202-223-5351 Email:
dktmichele@erols.com NEW MATERIALS AND
CAMPAIGNS The ASEC newsletter available on PATH
webpage The
ASEC electronic emergency contraception newsletter can now be found on
the PATH organization’s website, www.path.org
Readers can access previous editions of the newsletter in
addition to other information on legislation concerning EC in the United
States and internationally. There is also a link to the newsletter from
the references section of the emergency contraception website, www.not-2-late.com,
maintained by Princeton University’s Office of Population Research. Contact: Tara
Shochet Office
of Population Research Princeton
University Notestein
Hall 21
Prospect Street Princeton,
NJ 08544 USA Tel:
609-258-5402 Fax:
609-258-1039 Email:
shochet@princeton.edu
New
Consortium publication and updated medical guidelines The
Consortium for Emergency Contraception recently released a publication
documenting the Consortium’s history and experiences introducing a
dedicated emergency contraception product. The publication is designed
for policymakers, reproductive health program managers, and women’s
health advocates. Expanding Global Access to Emergency
Contraception: A Collaborative Approach to Meeting Women’s Needs
is divided into two sections. Part
I describes the Consortium’s collaboration with member organizations,
their relationship with private-sector manufacturers and distributors,
and their strategy for stimulating discussion about emergency
contraception. The first section also presents case studies from the
introduction activities in four model countries (Indonesia, Kenya,
Mexico, and Sri Lanka), and it includes results from each project’s
final evaluation reports. Part II of the publication includes emergency
contraception resources for providers and clients. The section has been
updated and expanded to include revised versions of instruments from the
original Consortium information packet, such as the Medical and
Service Delivery Guidelines, sample client information materials,
and an introduction framework. The
Consortium’s updated Medical and Service Delivery Guidelines also
are available as a separate publication for use during training or for
distribution to clinical staff. All
of these publications can be viewed on the Consortium web site, www.path.org
Please contact the Consortium to request copies.
Contact: Kimberly
Evans PATH 4
Nickerson Street Seattle,
WA 98109 USA Phone:
(206)285-3500 Fax:
(206)285-6619 Email:
kevans@path.org Emergency
contraception materials database The
Consortium for Emergency Contraception and the American Society for
Emergency Contraception are developing an EC materials database. The
database, which will include examples of materials from around the
world, is designed allow for organizations to share and adapt
information, ideas, and graphics related to emergency contraception
introduction and promotion. When completed, the database will be a
comprehensive catalogue of available materials about emergency
contraception and will include client educational materials, media
materials (TV, radio, and print materials), medical guidelines, training
curricula and novelty items. In addition, the database will include
information about target audiences, languages, copyright status,
availability and ordering information for all materials. Contact: Kimberly
Evans PATH 4
Nickerson Street Seattle,
WA 98109 USA Phone:
(206)285-3500 Fax:
(206)285-6619 Email:
kevans@path.org US
EC hotline and website expand to Canada The
emergency contraception website and hotline maintained by staff at the
Office for Population Research at Princeton University has recently
expanded to Canada. Now, information is available on names and telephone
numbers of clinicians in British Columbia who are willing to prescribe
emergency contraception by calling 1-888-NOT-2-LATE or logging on to www.not-2-late.com
The hotline also has a new
Spanish mnemonic 1-866-ENTRESDIAS.
Contact: Tara
Shochet Office
of Population Research Princeton
University Notestein
hall 21
Prospect Street Princeton,
NJ 08544 USA Tel:
609-258-5402 Fax:
609-258-1039 Email:
shochet@princeton.edu Planned Parenthood of Maryland starts “EC
to Go” campaign Planned
Parenthood of Maryland and the Baltimore City Health Department are
working together to distribute information about the recently launched
“EC to Go” campaign. “EC to Go” provides prescriptions for
emergency contraception in advance of need to women who present at
either Planned Parenthood health centers or state health clinics. In the
first six months of this fiscal year, 600 prescriptions for emergency
contraception were filled. The dedicated products PREVEN and Plan B are
also being distributed through these clinics. Contact: Roberta
Geidner-Antoniotti Planned
Parenthood of Maryland 610
N. Howard Street Baltimore,
MD 21201 USA Tel:
410-576-1400 Fax:
401-385-2762 Email:
ppmd@erols.com Boulder County, Colorado, Health Department
launches unintended pregnancy project including EC
Recently
the Boulder, Colorado, health department began a program to educate
their community about emergency contraception. The
“Unintended Pregnancy Project” was launched at the end of
March in the University of Colorado and University Hill communities to
reduce the rate of unwanted pregnancy. The health department distributed
posters and wallet-sized cards with information on EC and then measured
actual usage to determine if the intervention was successful. They
distributed approximately 13,800 cards on campus and an additional 5,000
cards through local businesses. Also, during the seven week program,
researchers at the health department surveyed women who requested
prescriptions for emergency contraception. A month after the program
began, providers were issuing twice as many prescriptions for EC as were
prescribed the previous year. Contact: Allison
Smith Boulder
County Health Department 3450
Broadway Boulder,
CO 80304 USA Tel:
303-441-1100 Fax:
303-441-1452 NARAL and others petition the FDA for over
the counter ECPs in the US This
past June, several women’s health research and advocacy organizations
testified before the FDA to urge sales of emergency contraception over
the counter in the United States. The National Abortion and Reproductive
Rights Action League (NARAL) and other organizations argued that
emergency contraception does not require a doctor’s diagnosis or other
guidance. They say it is safe and effective and meets the FDA’s
standards for over the counter distribution. As part of the testimony,
many advocates made reference to a recent study of providers listed on
the Emergency Contraception Hotline (888-NOT-2-LATE) showing that the
prescription requirement for EC is a barrier to access for many women. A
NARAL representative added that when women called during regular
business hours, only three out of four attempts to obtain ECPs resulted
in appointments or telephone prescriptions within 72 hours. Contact: Kate
Michelman NARAL 1156
15th Street Suite
700 Washington,
DC 20005 USA Tel:
202-973-3000 Fax:
202-973-3096 Email:
naral@naral.org Zero Population Growth
campaigns against Wal-Mart for refusing to carry EC Since the introduction of the
dedicated EC products Preven and Plan B in the United States, all except
one large pharmacy chain has stocked the products. In the fall of 1999,
Wal-Mart, the fifth largest pharmacy chain in the country sent a memo to
all company pharmacists prohibiting them to order, stock or dispense
Preven. Since then, many EC research and advocacy groups protested the
company’s decision. Recently, Zero Population Growth (ZPG) began a
media campaign to raise public awareness about the ban on emergency
contraception and to encourage the company to reverse their position.
ZPG’s president, Peter Kostmayer, held televised news conferences in
19 cities and media coverage appeared in 12 more cities.
ZPG estimates that coverage of the story reached 11 and a half
million households in the country. In addition to their media campaign,
ZPG has helped to deliver 41,000 petitions to Wal-Mart’s CEO, Lee
Scott. The organization
continues to campaign against Wal-Mart and posts more information on how
others can help on their website, www.zpg.org Contact: Jay Keller National Field Director Zero Population Growth 1400 16th St. NW
Suite 320 Washington, DC 20036 USA Tel:
202-332-2200 Fax:
202-332-2302 Email:
jay@zpg.org Pharmacists in Great Britain continue to
distribute EC Since
December 1999, pharmacists in three inner-city health action zones in
Great Britain have been providing emergency contraception to women free
and without prescription. So far, more than 70 pharmacies in Manchester,
Trafford, and Salford have joined the pilot program.
Women receive a ten minute consultation and sign a consent form
before they start the therapy. Over
half of the women who present for emergency contraception were in their
20s. The project is now being evaluated based on:
If
the pilot proves to be successful based on these criteria, it may be
adopted nationally. Contact: Ann
Furedi Director
of Communications British
Pregnancy Advisory Service Austy
Manor, Wootton Wawen, Solihull West
Midlands B95 6BX UNITED
KINGDOM Tel:
44-156-4796-1033 |